1. Introduction {#sec1-ijerph-17-05082}
===============

In the recent past large increases in COVID-19 cases and deaths continue to be reported worldwide, including the EU/EEA countries \[[@B1-ijerph-17-05082]\]. The WHO defined the pandemy of COVID-19 as a public health emergency, with serious worldwide consequences in the short, medium, and long term \[[@B2-ijerph-17-05082]\]. This pandemic already has a major impact on human communities, through the important effects on the health of individuals, through the overloading of health care services, but also through the complex effects induced by the measures of the social distancing of the population. In this context, researches focused on epidemiological issues are of real use, bringing new opportunities and perspectives for public health policies.

In Romania, the first confirmed SARS-CoV-2 virus infection was recorded on 26 February 2020, with 1--2 cases confirmed daily in the following days. From 10 March, the trend became ascending and the number of cases reached an average of 300 cases/day at the beginning of April \[[@B3-ijerph-17-05082]\]. At the time of conducting the research, the trend in Romania was towards an increase in the number of confirmed people through detection of viral RNA by PCR test. Compared to other EU countries, in Romania, the number of people infected with the virus is lower, maybe due to the low number of tests performed. Another factor to mention is the early adoption of social isolation measures by the population and the establishment of the state of emergency for one month by the authorities on 16 March 2020.

Initially, a large part of all confirmed cases was recorded as a result of close contact with infected persons arriving in Romania from abroad (about 300,000 people in 6 weeks from the beginning of the epidemic in Romania), or with their contacts. Subsequently, the share of community transmission increased in that period.

The complexity of the clinical manifestations of SARS-CoV-2 infection is the subject of numerous debates in the scientific world. In this sense, there are several standardization approaches. Mainly, the screening diagnosis is supported by the patient's epidemiological history (travel/residence in affected areas and/or contact with symptomatic persons during the last 14 days) and by clinical symptomatology (acute fever during the last 72 h which cannot be attributed to another etiological diagnosis) \[[@B4-ijerph-17-05082]\]. Most recent research indicates that infection with the SARS-CoV-2 virus commonly shows symptoms such as fever, dry or productive cough, dyspnoea, sore throat, myalgia, and fatigue, general weakness, and pain in the context of viral pneumonia \[[@B1-ijerph-17-05082],[@B5-ijerph-17-05082]\]. The symptoms described may vary depending on the age of the patients. For example, in adults occur, in order of frequency, fever, cough, chest tightness/pain, fatigue, and sore throat. In contrast, children are more often asymptomatic, with fever and cough being reported in relatively few cases \[[@B6-ijerph-17-05082]\].

On the other hand, other clinical elements have been proposed as useful for the diagnosis of the disease, such as digestive symptoms: diarrhoea, anorexia, and nausea \[[@B7-ijerph-17-05082]\]. In addition, some clinical manifestations, like anosmia and dysgeusia, although minor in appearance, are considered to have a pathognomonic character \[[@B8-ijerph-17-05082]\]. It should be noted that an important category of people infected with the SARS-CoV-2 virus is totally asymptomatic, but can transmit the disease, the percentage going up to 78%, according to some authors \[[@B9-ijerph-17-05082]\].

In Romania, the diagnosis of suspicion for SARS-CoV-2 infection is established in the following situations:(1)A patient with an acute respiratory infection, with sudden onset, having met at least one of three clinical criteria (cough, fever, shortness of breath/increased respiratory rate), without another aetiology that fully explains the clinical picture and with international travel history, within 14 days prior to symptom onset.(2)A patient with an acute respiratory infection, having been in close contact with a confirmed case of COVID-19 within 14 days prior to symptom onset.(3)A patient with pneumonia or severe acute respiratory infection (SARI), without another aetiology that fully explains the clinical picture.

Instead, a confirmed case is considered to be a person with laboratory confirmation of infection with SARS-CoV-2, regardless of clinical signs and symptoms \[[@B10-ijerph-17-05082]\]. Similarly, according to WHO guidelines, laboratory diagnosis of COVID-19 is based on a positive real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 \[[@B11-ijerph-17-05082]\].

Regarding the strategy of testing people in Romania for infection with the SARS-CoV-2 virus, the recommendations of the European Centre for Disease Prevention and Control (ECDC) and World Health Organization (WHO) were applied \[[@B12-ijerph-17-05082]\]. Thus, in order, the tests are prioritized (only at the physician's recommendation) for symptomatic persons with international travel history, symptomatic close contacts of confirmed cases, symptomatic medical-sanitary personnel, pneumonia or SARI cases with unspecified aetiology from all hospitals, institutionalized persons with symptoms, patients before the transplant procedure (asymptomatic) and hematopoietic stem cell donors before donation \[[@B13-ijerph-17-05082]\].

Worldwide, there have been numerous initiatives to provide support services for communities hard-pressed by the new clashes that have arisen during this difficult time. Therefore, reliable alternative technological solutions have been proposed to aid health professionals. They are mainly based on mobile internet technologies, such as mobile applications or personal-oriented digital platforms that can carry out population screening activities in a very short time. Essentially, these are self-administered questionnaires to interested persons, which allow identifying the symptomatology and the context of infectious risk \[[@B14-ijerph-17-05082]\]. These alternative or complementary methods to the classical laboratory test procedures become extremely useful when the testing capacity is exceeded by the very large number of new cases that have occurred, and/or when the logistical resources are limited. Furthermore, through the geographical tracking and mapping of infected people, it is possible to sustain the global fight against the COVID-19 outbreak \[[@B15-ijerph-17-05082]\].

2. Materials and Methods {#sec2-ijerph-17-05082}
========================

2.1. Premises and Aim of the Study {#sec2dot1-ijerph-17-05082}
----------------------------------

In Romania, the frequency of performing the population testing for the SARS-CoV-2 virus is relatively low, but the epidemiological situation seems to be still under control. However, there are certain risks to the short-term evolution of the pandemic, taking into account, for example, the massive tendency of returning people from risk areas. When returning to Romania, these persons are required to quarantine, or isolate for 14 days, at home or in special spaces. That is why it seems plausible that there are a much larger number of infected people than the one found by direct testing. Thus, the purpose of the study was to conduct a cross-sectional, descriptive, epidemiological investigation by administering an online survey regarding the prevalence of the specific symptomatology of the SARS-CoV-2 virus infection among the Romanian population. The present research aimed to contribute to the development of useful information resources, necessary for the management of a new disease, which has many unknowns.

2.2. Participants {#sec2dot2-ijerph-17-05082}
-----------------

The study was designed on a sample of the Romanian population. Thus, a number of 2013 people were initially voluntarily recruited into research, by completing the online questionnaire. Of these, 1830 persons were validated for the statistical processing of the data. The criteria for inclusion in the study refer to the current domicile in Romania and completing the questionnaire in full. The study was approved by our institutional ethical committee (registration number 387/31.03.2020) and all participants provided online informed consent to participate in the research.

2.3. Data Acquisition {#sec2dot3-ijerph-17-05082}
---------------------

For online data collection, the software PsyToolkit (<https://www.psytoolkit.org/>) was used \[[@B16-ijerph-17-05082],[@B17-ijerph-17-05082]\]. Thus, an online survey was developed, that includes two categories of items, with mandatory completion. The first category (10 items) consists of categorical socio-demographic variables of the participants: age, sex, domicile in a certain county in Romania, type of current residence, type of housing, social status, travel abroad in the last month, contact with a confirmed SARS-CoV-2 virus case, the current situation related to the social isolation imposed by law, the average number of contacts with people in the last two weeks. Of the 10 items, nine have closed-ended questions with a single answer and one item contains an open question (another situation in the context of social isolation imposed by law). The second category (22 items) includes variables that circumscribe the participants' health, from the physical and psychological point of view, and the 13 most relevant clinical features of infection with the SARS-CoV-2 virus. Of the 22 items, 21 are closed-ended questions with a single answer, and one item has a closed-ended question with multiple choice answers (comorbidities). The survey contains one numerical variable (age) and nominal variables converted to numerical dummy values.

In the preamble of the questionnaire, the participants were informed about the storage and use of the data for research purposes, under conditions of confidentiality and anonymity, according to the laws in force. The questionnaire could be completed by each participant or for any other person in his family (child, older people, etc.). The estimated average time to complete the survey was 3--4 min. The questionnaire could be freely distributed through social networks to increase the size of the sample of participants and was accessed through a dedicated link between 2 April 2020, and 7 April 2020.

2.4. Outcomes and Statistical Analysis {#sec2dot4-ijerph-17-05082}
--------------------------------------

The answers obtained were imported and statistically processed using IBM SPSS 20.0 software (IBM Corp., Armonk, NY, USA) in terms of descriptive statistics (mean, standard deviation, frequency distribution, multiple response analysis, Cronbach's alpha test for the internal consistency of the instrument) and inferential statistics (categorical principal component analysis with optimal scaling, two-step cluster analysis, followed by one-way ANOVA and Pearson's chi-square test, and binomial logistic regression).

3. Results {#sec3-ijerph-17-05082}
==========

This section may be divided by subheadings. It should provide a concise and precise description of the experimental results, their interpretation as well as the experimental conclusions that can be drawn.

3.1. Respondents {#sec3dot1-ijerph-17-05082}
----------------

From 2013 persons with current domicile in Romania, a number of 1830 participants were selected for statistical data processing (a response rate of 90.9%). Eligibility was based on completing the online questionnaire in full.

3.2. Sociodemographic Characteristics of Study Participants {#sec3dot2-ijerph-17-05082}
-----------------------------------------------------------

The mean respondent age was 33.54 ± 13.14 years, the age range varied between 4 and 90 years old, with a sex ratio of 0.369 (494 men/1336 women) and most respondents were between 18 and 50 years (85.6%). In terms of territorial distribution ([Table 1](#ijerph-17-05082-t001){ref-type="table"}), most of the participants (62.5%) come from a single district (Arges), in the second place (8.3%) being those from the country's capital (Bucharest), the rest being distributed relatively evenly across the country. This can be explained by the fact that initially the questionnaire was distributed on social networks, starting from the close acquaintances of the authors, followed by a branched distribution.

Other data with possible interest for the interpretation of social distancing refer to the fact that most respondents live in urban areas (71.2%), in individual housing (52.8%), are employed (56.4%), did not travel abroad in the last month (97%), did not have contact with a person infected with the SARS-CoV-2 virus (70.7%), are in self-insulation or confined at home (68.2%) and interacted in the last two weeks with an average of 1--5 people (68.1%).

3.3. Health Status Characteristics of Study Participants {#sec3dot3-ijerph-17-05082}
--------------------------------------------------------

Overall ([Table 2](#ijerph-17-05082-t002){ref-type="table"}), most participants were in good or very good health, based on self-assessment (75.5%), had not been tested for the SARS-CoV-2 virus (99.6%), had a mild or moderate level of physical activity in the last two weeks (66%), are non-smokers (72.1%), had no history of chronic illness (81.1%), have not had Influenza or acute respiratory infections in the last 6 months (75%) and have not been vaccinated for Influenza in the last 6 months (91.8%). Among the personal pathological antecedents, the most common are the cardiovascular ones (6.1%). Regarding the presence of symptoms associated with SARS-CoV-2 virus infection in the last 14 days, the following clinical elements were reported more frequently: headache (33.1%), nasal congestion/leakage of nasal secretions (20.8%), sore throat or dry throat sensation (19.4%) and muscle and/or joint pain (14.5%). The rest of the clinical features registered percentages between 0.8--8.8%. Also, most respondents stated that they have always or occasionally wore a face mask outside the home in the last 14 days (77.5%). Finally, from a psychological point of view, most participants had a mild or moderate level of anxiety about the pandemic with SARS-CoV-2 (71.6%).

3.4. Multiple Response Analysis {#sec3dot4-ijerph-17-05082}
-------------------------------

For the dichotomic items that represent the clinical features of SARS-CoV-2 infection, we applied a multiple response analysis to put into evidence people with multiple symptomatology ([Table 3](#ijerph-17-05082-t003){ref-type="table"}). It is observed that, in total, 1016 subjects (55.5%) reported at least one clinical element of those analyzed.

3.5. Reliability of the Survey Section for Clinical Features of SARS-CoV-2 Infection {#sec3dot5-ijerph-17-05082}
------------------------------------------------------------------------------------

To assess the internal consistency of the clinical features section of the survey (items h8--h20 from [Table 2](#ijerph-17-05082-t002){ref-type="table"}) we applied the Cronbach's Alpha.

The removal of item h9 led to a slight improvement in Cronbach's alpha. The reason we gave up this item is that it is redundant with the previous item h8, and 49.5% of respondents stated that they had not measured their body temperature in the last two weeks. In addition, in this way, all items considered for specific clinical features of infection with the SARS-CoV-2 virus (h8 and h10--h19) are of binary data type, with yes/no answers. Thus, the Cronbach's Alpha, based on standardized items, was 0.671, which is considered to be reasonable for a substantial sample \[[@B18-ijerph-17-05082]\] and for measuring a single construct with heterogeneous items, when usually the reliability is underestimated \[[@B19-ijerph-17-05082]\]. In fact, from [Table 4](#ijerph-17-05082-t004){ref-type="table"} negligible or low correlations can be observed between the analyzed clinical features. Of note, however, the highest correlations 0.357 between the items h14 and h15, respectively 0.327 between h11 and h17.

3.6. Categorical Principal Component Analysis (CATPCA) with Optimal Scaling {#sec3dot6-ijerph-17-05082}
---------------------------------------------------------------------------

We applied this data reduction technique with different numbers of items from our survey to arrive at a meaningful solution for further cluster analysis. This nonlinear method allows reducing numerous observed variables to a number of uncorrelated principal components and the representation of variables as vectors in regard to these components \[[@B20-ijerph-17-05082]\].

Based on the "Eigenvalue greater than one" criterion \[[@B21-ijerph-17-05082]\], we found two dimensions (components) to be analyzed. Thus, the CATPCA method helped us to reduce the initial set of 32 variables into 17 variables, grouped on two clusters that belong to the socio-demographic profile, respectively to the health profile of the participants ([Table 5](#ijerph-17-05082-t005){ref-type="table"} and [Table 6](#ijerph-17-05082-t006){ref-type="table"}). The two clusters were distributed into two dimensions by CATPCA, explaining together 31.98% of the total variance.

In [Figure 1](#ijerph-17-05082-f001){ref-type="fig"} we can observe two groups of correlated vectors pointing in the same direction, and the length of the vectors indicated the most dominant variables (s1, s6, s9, and respectively h11, h13, h10, h15, h17, h1, h12, h14). As a conclusion, CATPCA has categorized the balance of 17 variables into two different dimensions for the sociodemographic profile and the health status. Both dimensions are almost equally important because account for about as much variance (17.27% and 14.71%) and this reason must be interpreted together to describe different areas \[[@B22-ijerph-17-05082]\]. Also, all variables have a positive component loading in both dimensions, which means that there is a common factor that correlates positively with all of the variables for each dimension.

3.7. Two-Step Clustering Analysis {#sec3dot7-ijerph-17-05082}
---------------------------------

The two-step clustering analysis with the most dominant variables selected through CATPCA revealed a three-cluster solution ([Table 7](#ijerph-17-05082-t007){ref-type="table"}), with a "silhouette measure of cohesion and separation" of 0.25, indicating a fair cluster solution \[[@B23-ijerph-17-05082]\]. The variables in [Table 6](#ijerph-17-05082-t006){ref-type="table"} are hierarchized from top to bottom, from most to less discriminative between clusters. Statistical differences between clusters were compared using Pearson's Chi-square test for the categorical variables (s6, s9, h1, h10, h11, h12, h13, h14, h15, h17) and one-way ANOVA for the continuous variables (s1--age). For s1 item (age), the mean value is displayed, and for the categorical items, the percent (%) of records is displayed. All variables presented statistically significant differences in regard to the three clusters (*p* \< 0.001).

The three relevant clusters obtained were the following:(1)Cluster 1 (*n* = 491): participants mostly pupils/students (81.5%), young (mean age 22.77 years), with excellent or very good health (83.3%), self-insulated or confined at home (85.7%), who present in a very small proportion the analysed clinical features (between 0--1.2%).(2)Cluster 2 (*n* = 619): participants mostly employed (58.2%), mostly young adults (mean age 33.38 years), in very good or good health (79.6%), self-insulated or confined at home (68.8%), who present in a higher proportion the analysed clinical features (1.4--57.4%).(3)Cluster 3 (*n* = 720): participants mostly employed (83.6%), mostly adults (mean age 41.01 years), with excellent or very good health (65.3), heterogeneous in terms of social isolation, who present in very small proportion the analysed clinical features (0--2.2%).

3.8. Binomial Logistic Regression Analysis {#sec3dot8-ijerph-17-05082}
------------------------------------------

A binomial logistic regression (BLR) was repeatedly performed to ascertain the effects of sociodemographic and health characteristics on the likelihood that participants have the clinical features of SARS-CoV-2 infection. After checking the required assumptions, we run the BLR for each clinical feature item (variables with dichtotomous scale, h8, and h10--h20 items) as the dependent variable, and a model with 11 selected items as independent variables (based on the principle of avoiding multicollinearity): s1, s2, s4, s5, s7, h2, h4, h5, h6, h7, and h21. The logistic regression model was statistically significant (*p* \< 0.001) for h10--h19 items ([Table 8](#ijerph-17-05082-t008){ref-type="table"}).

[Table 8](#ijerph-17-05082-t008){ref-type="table"} shows the percentages of variance (Nagelkerke R^2^) that can be attributed to the investigated regression models and the Odds Ratios (OR) for each variable with statistically significant influence in the regression model. These results ([Table 8](#ijerph-17-05082-t008){ref-type="table"}) will be commented on in the Discussion section.

4. Discussion {#sec4-ijerph-17-05082}
=============

The present study did not set as its objective the diagnosis of people infected with the SARS-CoV-2 virus, but only the identification of the presence of clinical features that are specific to this disease among the population. The subject is very topical in light of current discussions about the pandemic trend, the movement restrictions imposed at the community level, but also the limited possibilities of mass testing. The identification of risk groups is essential for the subsequent efficient application of the measures of diagnostic, isolation, quarantine, treatment, etc. of the selected cases.

First of all, from this study a series of descriptive informational elements can be detached, which can be analyzed and interpreted in the specific Romanian situational context (for example, the percentage of smokers, the level of Influenza vaccination of the population, the respondent's level of physical activity, the psychological impact of the pandemic, etc.). It should be mentioned that at the time of completing the data gathering in Romania, 4417 cases of SARS-CoV-2 virus infection were confirmed, 196 deaths were caused by this disease, and about 45,000 diagnostic rRT-PCR tests were performed \[[@B24-ijerph-17-05082]\].

Within the two weeks considered, we identified single or associated clinical features that are part of the diagnostic criteria of SARS-CoV-2 virus infection, in a significant percentage of participants (55.5%). In other words, the percentage of detection of clinical elements among the studied sample varied between 33.1% for headache and 0.8% for loss of taste and/or odour. Not all individuals are carriers of the virus, the symptoms of this disease being diverse \[[@B25-ijerph-17-05082]\] and largely nonspecific, mainly associated with respiratory and few extrapulmonary signs \[[@B26-ijerph-17-05082]\]. On average, subjects who reported symptoms had 2.25 clinical features per individual. The highest correlation recorded (but of low intensity) was between chest pain or chest pressure sensation and dyspnoea (breathing difficulty), suffocation, and/or shortness of breath, respectively between increased fatigue and muscle and/or joint pain. Our results suggest the presence of possible acute respiratory infections among respondents, which may have various aetiologies. Given the present epidemiological situation, we cannot exclude, in a part of the study sample, the variant of infection with the SARS-CoV-2 virus, or the variant of infection or co-infection with other respiratory viruses. The underdiagnoses of SARS-CoV-2 virus infection in the context of respiratory viral coinfections \[[@B27-ijerph-17-05082]\], as well as the frequent spread in the population of asymptomatic, presymptomatic or paucisymptomatic forms of the disease, remains a matter of debate \[[@B9-ijerph-17-05082],[@B28-ijerph-17-05082]\]. However, in the case of Romania, paradoxically, the number of people infected with the SARS-CoV-2 virus and the consecutive deaths were well below the European average at the beginning of the pandemic, a situation that can have multiple explanations. Nevertheless, it remains open the hypothesis according to which the disease may be far more frequent among people of Romania and its prevalence may be underestimated, similar to other countries \[[@B29-ijerph-17-05082]\].

The section of our survey for clinical features assessment of infection with SARS-CoV-2 had an acceptable internal consistency. Since we are talking about a condition with a high polymorphism, in which most individuals are asymptomatic or have mild forms \[[@B30-ijerph-17-05082]\], the instrument appears to be reliable for early digital health screening, and also easy to be implemented.

Following the application of CATPCA as data reduction technique for the entire survey, the outcomes of the categorized variables showed that we can use only 17 items to investigate the multifaceted profile of the sample group, related to the infection with SARS-CoV-2 virus. Practically, we succeeded to classify the variables into two meaningful dimensions and the total variance is explained for the principal components solution to a percentage of 31.98%. The CATPCA results mapped the nature of the interaction between the sociodemographic profile and the health status of the respondents and therefore we validated the proposed categorization attempt for classification procedure.

Next, we introduced the CATPCA results in a two-step cluster analysis and we reported a model with three meaningful classificatory clusters, statistically different in regard to the variables considered (*p* \< 0.001). Differentiating the three clusters is important because it offers the possibility of separating a risk group for the disease. Thus, the subjects from the second cluster were the most clinically affected, with a heterogeneity of symptoms, but without presenting serious clinical forms of the disease. Identifying this cluster becomes useful because it includes people at higher risk of actually being infected with the SARS-CoV-2 virus. In contrast, the other two clusters (one for young people and one for adults) stand out through a better state of health and almost no clinical manifestations. The hierarchical distribution of clinical features on clusters according to their predictive value is also interesting, the order being h13, h17, h11, h12, h14, h15, h10, different from the one resulting from the CATPCA analysis, according to variance. From the same point of view, prominent hierarchical positions have the social status (s6) and age (s1 item), as determinants of the sociodemographic profile of the subjects.

Most of the symptoms described are superimposable with the major clinical manifestations in all coronavirus infections, including the one with SARS-CoV-2 virus (fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhoea, confusion, dyspnoea, and pneumonia \[[@B25-ijerph-17-05082]\]. Multiple studies report the prevalent clinical manifestations for SARS-CoV-2 infection like fever, cough, dyspnoea, with a fever frequency significantly higher in adults compared to children \[[@B6-ijerph-17-05082],[@B26-ijerph-17-05082],[@B31-ijerph-17-05082]\]. In our study, the second cluster presented the most important fields in estimating the model, based on the predictor importance, in order: the social status, sore throat or dry throat sensation, age, muscle and/or joint pain, and increased fatigue.

It should be mentioned the absence of fever in the last 14 days as an important emerging variable in CATPCA analysis, which is why it was not included in the two-step cluster analysis. This can be correlated with the fact that 49.5% of the subjects stated that they did not measure their temperature during the considered period. Moreover, it has been shown that the correct self-perception of fever is achieved in about 80% of cases if the body temperature is higher than 38 °C \[[@B32-ijerph-17-05082]\]. We can plausibly consider that the subfebrile states were not noticed by the respondents and/or the fever does not represent a significant feature for the mild forms of registered respiratory infections. In this regard we recall the results of recent research that estimate that a significant part of people tested positive for SARS-CoV-2 virus infection, with potential for disease transmission, are asymptomatic or have a mild illness, with low or absent fever \[[@B33-ijerph-17-05082]\]. Yet another study claims that among people confirmed positive for SARS-CoV-2 virus, fever was uncommon (0.7%), and most individuals (87.8%) were asymptomatic \[[@B34-ijerph-17-05082]\].

The results must be interpreted taking into account the testing strategy for SARS-CoV-2 virus in Romania, which implies a prioritization of the subjects according to the medical context, epidemiological investigations, and also the available resources. Even in the most developed countries, the rRT-PCR testing is applied in selected cases, due to the low availability of key supplies \[[@B35-ijerph-17-05082]\]. The situation in Romania is also comparable to that of many European countries, which have a similar testing strategy, based on WHO recommendations \[[@B36-ijerph-17-05082]\].

In the final stage of the research, a binomial logistic model was tested to establish the relationship between the likelihood that the clinical features of the infection with SARS-CoV-2 are related to the selected predictor variables. The results presented in [Table 8](#ijerph-17-05082-t008){ref-type="table"} revealed that some predictors are significantly associated with most clinical features (items h10--h19). The most relevant associations according to the proposed regression model refer to predictor items h4, h5, h6, and h21 and s1. Thus, the odds of having some clinical features were greater for smokers, for people with chronic diseases, and people with Influenza or acute respiratory infections in the last 6 months. Also, the systematic face mask wearing outside the home represents a protection factor against the development of clinical features, and increasing age was associated with a higher likelihood of exhibiting some clinical features. However, the Nagelkerke R^2^ values were relatively small, even the logistic regression models were statistically significant. In other words, the contribution of the mentioned explanatory variables in the prediction of clinical features is statistically significant, but the interpretation must be made with caution because the effect size is small.

Other studies confirm smoking as a risk factor for infection with the SARS-CoV-2 virus, causing more severe forms of the disease \[[@B37-ijerph-17-05082],[@B38-ijerph-17-05082]\]. In the same sense of interpretation, it has been shown that the infection with the SARS-CoV-2 virus is more frequent in patients with chronic medical conditions \[[@B31-ijerph-17-05082],[@B39-ijerph-17-05082]\] and with a higher lethality \[[@B40-ijerph-17-05082]\]. Our results also indicated the additional risk of presenting clinical symptoms after an episode of Influenza or respiratory acute infection in the last 6 months. Interestingly, the chronic respiratory infections appear to be under-represented in the comorbidities reported for patients with COVID-19, possibly due to an altered immune response or therapies used in these cases \[[@B41-ijerph-17-05082]\]. Instead, our data suggest that the status of post-acute respiratory infection increases the risk for respiratory reinfection, possibly with the SARS-CoV-2 virus.

Another notable result of our study was the finding of the protective effect of constant wearing a protective mask when moving out of the home. Thus, this fact has been revealed in meta-analyses that have investigated the effectiveness of these physical methods, as simple and low-cost interventions, to reduce respiratory virus infections \[[@B42-ijerph-17-05082],[@B43-ijerph-17-05082]\]. Finally, our results confirmed that the risk of presenting the investigated clinical symptoms increases proportionally with age, the young ages being generally spared, as other authors stated \[[@B6-ijerph-17-05082],[@B44-ijerph-17-05082],[@B45-ijerph-17-05082]\].

Overall, we proved the practical usefulness of a survey of self-reporting tracking of symptoms of the SARS-CoV-2 virus. At the moment there is a special interest in developing such web-designed applications and researchers are looking for some predictive models based on clinical symptoms of the disease, which can contribute to target screening strategies \[[@B46-ijerph-17-05082]\]. In conclusion, through the statistical approach, we managed to validate the key elements of a survey that can identify a risk group for presenting the specific clinical features of SARS-CoV-2 virus infection, during social distancing imposed by the pandemic situation. Further testing of people at risk for infection will allow the detection of real cases, which require a complex therapeutic approach. Nevertheless, the administration of the questionnaire also has educational and formative values as it helps respondents to acquire knowledge on the clinical manifestations of the SARS-CoV-2 infection. In this way, they can better understand the disease and the importance of self-management of healthy behaviors.

Limitations and Strengths of the Study
--------------------------------------

One limitation of the study derives from the heterogeneous distribution of the subjects' age, sex, and territory of residence. This is explained by the fact that the survey was distributed on the web according to the model of social network circles, starting from the authors of the article. Also, it remains to be discussed, as in any study of this type, the honesty of the respondents in conditions of anonymity, as well as their subjectivism in selecting the appropriate answers. Another limitation of the study refers to the low proportion of older adults in the sample, this age group being the most affected by SARS-CoV-2 infection. Instead, the large number of respondents, the accessibility of the questions in terms of content, the very short time to complete the questionnaire, the rapid construction of the database, and the complex statistical analysis of the data proved to be strengths of the research.

5. Conclusions {#sec5-ijerph-17-05082}
==============

The present study validated a cost-effective model for rapid assessment of the health status of the Romanian population in the form of an online survey, adapted to the existential circumstances of the SARS-CoV-2 virus pandemic. We determined a reasonable reliability of the survey section for clinical features of SARS-CoV-2 infection (Cronbach's Alpha 0.671). The CATPCA analysis followed by a two-step cluster analysis revealed a three-cluster solution, with significant differences between clusters (*p* \< 0.001), which allowed the cluster detection of a group of individuals, possibly more affected by the infection with the SARS-CoV-2 virus. Through binomial logistic regression analysis we identified a statistically significant prediction model for the presumptive diagnostic of some relevant clinical features of the infection with the SARS-CoV-2 virus.

Our survey could be easily applied on a large scale, at an institutional level to monitor in real time the health of people facing the consequences of the pandemic. Thus, the approach can support the efforts of making prompt decisions regarding the implementation of health programs, population diagnostic screening, isolation/quarantine of risk groups, and/or hospitalization of serious cases.
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###### 

Summary of the sociodemographic characteristics of study participants (N = 1830).

  ---------------------------------------------------------------------------------------------------------------------
  Item Code                 Variable                                                            Frequency\   Percent\
                                                                                                (*n*)        (%)
  ------------------------- ------------------------------------------------------------------- ------------ ----------
  s1                        Age                                                                              

  4--17 years               49                                                                  2.7          

  18--50 years              1567                                                                85.6         

  51--64 years              180                                                                 9.8          

  65--90 years              34                                                                  1.9          

  s2                        Sex                                                                              

  Male                      494                                                                 27           

  Female                    1336                                                                73           

  s3                        Domicile (42 districts)                                                          

  District 3 (Arges)        1144                                                                62.5         

  District 42 (Bucharest)   152                                                                 8.3          

  Rest of districts         534                                                                 29.2         

  s4                        Type of current residence                                                        

  Urban                     1303                                                                71.2         

  Rural                     527                                                                 28.8         

  s5                        Type of housing                                                                  

  Individual building       966                                                                 52.8         

  Collective building       864                                                                 47.2         

  s6                        Social status                                                                    

  Toddler/pre-schooler      3                                                                   0.2          

  Pupil/Student             583                                                                 31.8         

  Employee                  1033                                                                56.4         

  Freelancer                95                                                                  5.2          

  Unemployed                17                                                                  0.9          

  Retired                   54                                                                  3            

  Housewife/househusband    45                                                                  2.5          

  s7                        Travel abroad in the last month                                                  

  Yes                       55                                                                  3            

  No                        1775                                                                97           

  s8                        Contact with a confirmed SARS-CoV-2 case                                         

  Yes                       6                                                                   0.3          

  No                        1294                                                                70.7         

  I don't know              530                                                                 29           

  s9                        Current situation related to the social distancing imposed by law                

  Quarantine                69                                                                  3.8          

  Self-insulated            831                                                                 45.4         

  Hospitalized              1                                                                   0.1          

  Confined at home          417                                                                 22.8         

  In the workplace          253                                                                 13.8         

  Another situation         259                                                                 14.1         

  s10                       Average number of contacts with people in the last two weeks                     

  None                      165                                                                 9            

  1--5 people               1246                                                                68.1         

  6--10 people              197                                                                 10.8         

  More than 10 people       222                                                                 12\.         
  ---------------------------------------------------------------------------------------------------------------------
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###### 

Summary of the health status characteristics of study participants (N = 1830).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Item Code                                                         Variable                                                                                                           Frequency\   Percent\
                                                                                                                                                                                       (*n*)        (%)
  ----------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------ ----------
  h1                                                                Qualitative self-assessment of the health status                                                                                

  Excellent                                                         363                                                                                                                19.8         

  Very good                                                         821                                                                                                                44.9         

  Good                                                              560                                                                                                                30.6         

  Satisfying                                                        75                                                                                                                 4.1          

  Weak                                                              11                                                                                                                 0.6          

  h2                                                                Testing for SARS-CoV-2 virus                                                                                                    

  Tested positive                                                   0                                                                                                                  0            

  Tested negative                                                   8                                                                                                                  0.4          

  Non-tested                                                        1822                                                                                                               99.6         

  h3                                                                Maximum level of physical activity achieved in the last two weeks                                                               

  Very easy                                                         438                                                                                                                23.9         

  Mild                                                              462                                                                                                                25.3         

  Moderate                                                          745                                                                                                                40.7         

  Vigorous                                                          142                                                                                                                7.8          

  Very heavy                                                        22                                                                                                                 1.2          

  Maximal                                                           21                                                                                                                 1.1          

  h4                                                                Smoking                                                                                                                         

  Yes                                                               510                                                                                                                27.9         

  No                                                                1320                                                                                                               72.1         

  h5                                                                Pathological personal history 1---chronic cardiovascular diseases                                                               

  Yes                                                               112                                                                                                                6.1          

  No                                                                1718                                                                                                               93.9         

  Pathological personal history 2---chronic respiratory diseases                                                                                                                                    

  Yes                                                               56                                                                                                                 3.1          

  No                                                                1774                                                                                                               96.9         

  Pathological personal history 3---chronic neurological diseases                                                                                                                                   

  Yes                                                               19                                                                                                                 1            

  No                                                                1811                                                                                                               99           

  Pathological personal history 4---chronic renal diseases                                                                                                                                          

  Yes                                                               26                                                                                                                 1.4          

  No                                                                1804                                                                                                               98.6         

  Pathological personal history 5---chronic rheumatic diseases                                                                                                                                      

  Yes                                                               87                                                                                                                 4.8          

  No                                                                1743                                                                                                               95.2         

  Pathological personal history 6---diabetes mellitus                                                                                                                                               

  Yes                                                               22                                                                                                                 1.2          

  No                                                                1808                                                                                                               98.8         

  Pathological personal history 7---oncological diseases                                                                                                                                            

  Yes                                                               12                                                                                                                 0.7          

  No                                                                1818                                                                                                               99.3         

  Pathological personal history 8---others                                                                                                                                                          

  Yes                                                               97                                                                                                                 5.3          

  No                                                                1733                                                                                                               94.7         

  Pathological personal history 9---none                                                                                                                                                            

  Without chronic diseases                                          1484                                                                                                               81.1         

  With chronic diseases                                             346                                                                                                                18.9         

  h6                                                                Influenza or acute respiratory infections in the last 6 months                                                                  

  Yes                                                               457                                                                                                                25           

  No                                                                1373                                                                                                               75           

  h7                                                                Influenza vaccination in the last 6 months                                                                                      

  Yes                                                               150                                                                                                                8.2          

  No                                                                1680                                                                                                               91.8         

  h8                                                                Clinical feature 1---fever in the last 14 days                                                                                  

  Yes                                                               21                                                                                                                 1.1          

  No                                                                1809                                                                                                               98.9         

  h9                                                                Clinical feature 2---maximum body temperature measured in the last 14 days                                                      

  36.5 °C                                                           684                                                                                                                37.4         

  37 °C                                                             186                                                                                                                10.2         

  37.5 °C                                                           40                                                                                                                 2.2          

  38 °C                                                             7                                                                                                                  0.4          

  38.5 °C                                                           6                                                                                                                  0.3          

  Non-measured                                                      907                                                                                                                49.5         

  h10                                                               Clinical feature 3---chills and/or increased perspiration in the last 14 days                                                   

  Yes                                                               61                                                                                                                 3.3          

  No                                                                1769                                                                                                               96.7         

  h11                                                               Clinical feature 4---increased fatigue in the last 14 days                                                                      

  Yes                                                               161                                                                                                                8,8          

  No                                                                1669                                                                                                               91.2         

  h12                                                               Clinical feature 5---episodes of persistent dry or productive cough in the last 14 days                                         

  Yes                                                               154                                                                                                                8.4          

  No                                                                1676                                                                                                               91.6         

  h13                                                               Clinical feature 6---sore throat or dry throat sensation in the last 14 days                                                    

  Yes                                                               355                                                                                                                19.4         

  No                                                                1475                                                                                                               80.6         

  h14                                                               Clinical feature 7---chest pain or chest pressure sensation in the last 14 days                                                 

  Yes                                                               99                                                                                                                 5.4          

  No                                                                1731                                                                                                               94.6         

  h15                                                               Clinical feature 8---dyspnoea (breathing difficulty), suffocation and/or shortness of breath in the last 14 days                

  Yes                                                               82                                                                                                                 4.5          

  No                                                                1748                                                                                                               95.5         

  h16                                                               Clinical feature 9---headache in the last 14 days                                                                               

  Yes                                                               606                                                                                                                33.1         

  No                                                                1224                                                                                                               66.9         

  h17                                                               Clinical feature 10---muscle and/or joint pain in the last 14 days                                                              

  Yes                                                               265                                                                                                                14.5         

  No                                                                1565                                                                                                               85.5         

  h18                                                               Clinical feature 11---nasal congestion/leakage of nasal secretions in the last 14 days                                          

  Yes                                                               381                                                                                                                20.8         

  No                                                                1449                                                                                                               79.2         

  h19                                                               Clinical feature 12---diarrhoea, nausea, loss of appetite and/or vomiting in the last 14 days                                   

  Yes                                                               93                                                                                                                 5.1          

  No                                                                1737                                                                                                               94.9         

  h20                                                               Clinical feature 13---loss of taste and/or odour in the last 14 days                                                            

  Yes                                                               14                                                                                                                 0.8          

  No                                                                1816                                                                                                               99.2         

  h21                                                               Face mask wearing outside the home in the last 14 days                                                                          

  Always                                                            852                                                                                                                46.6         

  Occasionally                                                      566                                                                                                                30.9         

  Never                                                             412                                                                                                                22.5         

  h22                                                               Anxiety level in the context of the pandemic with SARS-CoV-2                                                                    

  Not anxious                                                       350                                                                                                                19.1         

  Mild anxious                                                      747                                                                                                                40.8         

  Moderately anxious                                                563                                                                                                                30.8         

  Very anxious                                                      133                                                                                                                7.3          

  Extremely anxious                                                 37                                                                                                                 2            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Multiple response analysis, frequencies and percent of cases.

              Responses   Percent of Cases            
  ----------- ----------- ------------------ -------- ------
  Items ^a^   h8          21                 0.9%     2.1%
  h10         61          2.7%               6.0%     
  h11         161         7.0%               15.8%    
  h12         154         6.7%               15.2%    
  h13         355         15.5%              34.9%    
  h14         99          4.3%               9.7%     
  h15         82          3.6%               8.1%     
  h16         606         26.4%              59.6%    
  h17         265         11.6%              26.1%    
  h18         381         16.6%              37.5%    
  h19         93          4.1%               9.2%     
  h20         14          0.6%               1.4%     
  Total       2292        100.0%             225.6%   

^a^ Dichotomy group tabulated at value 1 (answer yes)
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###### 

Inter-item correlation matrix (clinical features of SARS-CoV-2 infection).

        h8       h10     h11     h12     h13     h14     h15     h16     h17     h18     h19     h20
  ----- -------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  h8    1.000                                                                                    
  h10   0.237    1.000                                                                           
  h11   0.093    0.265   1.000                                                                   
  h12   0.078    0.163   0.191   1.000                                                           
  h13   0.103    0.186   0.218   0.269   1.000                                                   
  h14   0.065    0.144   0.190   0.154   0.176   1.000                                           
  h15   0.125    0.122   0.231   0.248   0.174   0.357   1.000                                   
  h16   0.077    0.141   0.212   0.130   0.254   0.155   0.117   1.000                           
  h17   0.072    0.174   0.327   0.155   0.195   0.149   0.129   0.212   1.000                   
  h18   0.058    0.122   0.135   0.252   0.232   0.109   0.091   0.223   0.118   1.000           
  h19   0.092    0.096   0.165   0.073   0.144   0.154   0.106   0.154   0.159   0.151   1.000   
  h20   −0.009   0.089   0.083   0.109   0.084   0.034   0.042   0.005   0.071   0.109   0.065   1.000
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###### 

Model summary for CATPCA.

  Dimension   Cronbach's Alpha   Variance Accounted For           
  ----------- ------------------ ------------------------ ------- --------
  1           0.701              2.937                    0.173   17.277
  2           0.638              2.501                    0.147   14.710
  Total                          5.438                    0.320   
  Mean        0.672 ^a^          2.719                    0.160   15.993

^a^ Mean Cronbach's Alpha is based on the mean eigenvalue.
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###### 

Discrimination measures for CATPCA.

                   Dimension   Mean     
  ---------------- ----------- -------- --------
  s1               0.171       0.677    0.424
  s3               0.071       0.175    0.123
  s6               0.075       0.624    0.350
  s8               0.134       0.117    0.125
  s9               0.032       0.373    0.203
  s10              0.056       0.202    0.129
  h1               0.239       0.029    0.134
  h8               0.112       0.029    0.070
  h9               0.116       0.106    0.111
  h10              0.255       0.009    0.132
  h11              0.310       0.030    0.170
  h12              0.230       0.012    0.121
  h13              0.258       0.009    0.133
  h14              0.221       0.007    0.114
  h15              0.240       0.017    0.128
  h16              0.178       0.055    0.116
  h17              0.239       0.032    0.135
  Active Total     2.937       2.501    2.719
  \% of Variance   17.277      14.710   15.993
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###### 

Characteristics of the three clusters identified by two-step clustering with variable selection based on CATPCA.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Item Code                Variable                                                                                                               Cluster 1\     Cluster 2\      Cluster 3\      *p* Value
                                                                                                                                                  *n* = 491      *n* = 619       *n* = 720       
  ------------------------ ---------------------------------------------------------------------------------------------------------------------- -------------- --------------- --------------- ------------------
  s6                       Social status (%)                                                                                                                                                     *p* \< 0.001 ^a^

  Toddler/pre-schooler     0.6%                                                                                                                   0              0                               

  Pupil/Student            81.5%                                                                                                                  29.6%          0                               

  Employee                 14.5%                                                                                                                  58.2%          83.6%                           

  Freelance                0                                                                                                                      6.1%           7.9%                            

  Unemployed               0.6%                                                                                                                   0.8%           1.2%                            

  Retired                  0                                                                                                                      2.1%           5.7%                            

  Housewife/househusband   2.9%                                                                                                                   3.2%           1.5%                            

  h13                      Clinical feature 6---sore throat or dry throat sensation in the last 14 days (%)                                                                                      *p* \< 0.001 ^a^

  Yes                      0                                                                                                                      57.4%          0                               

  No                       100%                                                                                                                   42.6%          100%                            

  s1                       Age (mean ± SD, years)                                                                                                 22.77 ± 6.45   33.38 ± 12.84   41.01 ± 11.59   *p* \< 0.001 ^b^

  h17                      Clinical feature 10---muscle and/or joint pain in the last 14 days (%)                                                                                                *p* \< 0.001 ^a^

  Yes                      1.2%                                                                                                                   39.3%          2.2%                            

  No                       98.8%                                                                                                                  60.7%          97.8%                           

  h11                      Clinical feature 4---increased fatigue in the last 14 days (%)                                                                                                        *p* \< 0.001 ^a^

  Yes                      0.2%                                                                                                                   25.5%          0.3%                            

  No                       99.8%                                                                                                                  74.5%          99.7%                           

  h12                      Clinical feature 5---episodes of persistent dry or productive cough in the last 14 days (%)                                                                           *p* \< 0.001 ^a^

  Yes                      1%                                                                                                                     23.1%          0.8%                            

  No                       99%                                                                                                                    76.9%          99.2%                           

  s9                       Current situation related to the social distancing imposed by law                                                                                                     *p* \< 0.001 ^a^

  Quarantine               7.7%                                                                                                                   4.2%           0.7%                            

  Self-insulated           50.9%                                                                                                                  48%            39.4%                           

  Hospitalized             0.2%                                                                                                                   0              0                               

  Confined at home         34.8%                                                                                                                  20.8%          16.2%                           

  In the workplace         0.6%                                                                                                                   16.3%          20.7%                           

  Another situation        5.7%                                                                                                                   10.7%          22.9%                           

  h14                      Clinical feature 7---chest pain or chest pressure sensation in the last 14 days (%)                                                                                   *p* \< 0.001 ^a^

  Yes                      1.2%                                                                                                                   1.4%           0.1%                            

  No                       98.8%                                                                                                                  85.1%          99.9%                           

  h15                      Clinical feature 8---dyspnoea (breathing difficulty), suffocation and/or shortness of breath in the last 14 days (%)                                                  *p* \< 0.001 ^a^

  Yes                      0.4%                                                                                                                   12.9%          0                               

  No                       99.6%                                                                                                                  87.1%          100%                            

  h1                       Qualitative self-assessment of the health status (%)                                                                                                                  *p* \< 0.001 ^a^

  Excellent                32%                                                                                                                    10.8%          19.3%                           

  Very good                51.1%                                                                                                                  38.6%          46%                             

  Good                     16.5%                                                                                                                  41%            31.2%                           

  Satisfying               0.2%                                                                                                                   8.4%           3.1%                            

  Weak                     0.2%                                                                                                                   1.1%           0.4%                            

  h10                      Clinical feature 3---chills and/or increased perspiration in the last 14 days (%)                                                                                     *p* \< 0.001 ^a^

  Yes                      0%                                                                                                                     9.9%           0                               

  No                       100%                                                                                                                   90.1%          100%                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Pearson's Chi-square test. ^b^ One-way ANOVA.
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###### 

Outputs of binomial logistic regression analysis (N = 1830).

  Independent Variable   Omnibus Test of Model Coefficients   Model Summary   Regression Coefficients and Significance Level                                           
  ---------------------- ------------------------------------ --------------- ------------------------------------------------ ------- -------- ------- -------------- -------
  h10                    37.575                               0.001           0.080                                            h6      1.188    3.281   1.942--5.542   0.001
  h11                    52.059                               0.001           0.062                                            h4      0.573    1.774   1.254--2.509   0.001
  h5 \*                  0.724                                2.062           1.376--3.091                                     0.001                                   
  h6                     0.791                                2.205           1.571--3.095                                     0.001                                   
  h21 (1)                −0.549                               0.578           0.382--0.873                                     0.009                                   
  h12                    118.563                              0.001           0.143                                            s5      −0.434   0.648   0.428--0.982   0.041
  h4                     0.662                                1.938           1.348--2.786                                     0.001                                   
  h5 \*                  0.706                                2.026           1.343--3.058                                     0.001                                   
  h6                     1.554                                4.729           3.341--6.693                                     0.001                                   
  h13                    43.370                               0.001           0.037                                            h6      0.722    2.059   1.602--2.646   0.001
  h14                    36.785                               0.001           0.058                                            h4      0.842    2.322   1.522--3.543   0.001
  h5 \*                  0.621                                1.860           1.126--3.072                                     0.015                                   
  h6                     0.574                                1.776           1.156--2.728                                     0.009                                   
  h21 (1)                −0.688                               0.502           0.298--0.847                                     0.010                                   
  h15                    62.828                               0.001           0.110                                            h4      0.690    1.994   1.238--3.212   0.005
  h5 \*                  1.334                                3.796           2.271--6.343                                     0.001                                   
  h6                     0.954                                2.596           1.640--4.109                                     0.001                                   
  h21 (1)                −0.995                               0.370           0.205--0.666                                     0.001                                   
  h21 (2)                −0.709                               0.492           0.282--0.859                                     0.013                                   
  h16                    94.766                               0.001           0.070                                            s1      0.027    1.028   1.019--1.037   0.001
  s2                     −0.384                               0.681           0.538--0.862                                     0.001                                   
  h4                     0.404                                1.498           1.203--1.866                                     0.001                                   
  h5 \*                  0.299                                1.348           1.021--1.780                                     0.035                                   
  h6                     0.424                                1.528           1.218--1.915                                     0.001                                   
  h17                    58.030                               0.001           0.055                                            h4      0.429    1.536   1.154--2.043   0.003
  h5 \*                  0.731                                2.078           1.499--2.882                                     0.001                                   
  h6                     0.612                                1.844           1.392--2.444                                     0.001                                   
  h18                    50.597                               0.001           0.043                                            s1      0.11     1.011   1.001--1.021   0.028
  h4                     0.294                                1.342           1.045--1.724                                     0.021                                   
  h6                     0.601                                1.824           1.423--2.336                                     0.001                                   
  h21 (1)                −0.433                               0.649           0.484--0.869                                     0.004                                   
  h21 (2)                −0.399                               0.712           0.544--0.931                                     0.013                                   
  h19                    37.646                               0.001           0.062                                            s1      0.040    1.041   1.021--1.062   0.001
  s7                     1.020                                2.772           1.126--6.823                                     0.027                                   
  h5 \*                  0.703                                2.020           1.193--3.419                                     0.009                                   
  h6                     0.721                                2.057           1.325--3.192                                     0.001                                   

Note: \* subitem h5 (Pathological personal history 9---none); OR---Odds Ratio; *p*---significance level; for all items, the last answer represents the reference category; (1): always wearing face mask; (2): occasionally wearing face mask
